1. Home
  2. LEGN vs TAL Comparison

LEGN vs TAL Comparison

Compare LEGN & TAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • TAL
  • Stock Information
  • Founded
  • LEGN 2014
  • TAL 2003
  • Country
  • LEGN United States
  • TAL China
  • Employees
  • LEGN N/A
  • TAL N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • TAL Other Consumer Services
  • Sector
  • LEGN Health Care
  • TAL Real Estate
  • Exchange
  • LEGN Nasdaq
  • TAL Nasdaq
  • Market Cap
  • LEGN 7.0B
  • TAL 5.9B
  • IPO Year
  • LEGN 2020
  • TAL 2010
  • Fundamental
  • Price
  • LEGN $32.80
  • TAL $9.80
  • Analyst Decision
  • LEGN Strong Buy
  • TAL Strong Buy
  • Analyst Count
  • LEGN 12
  • TAL 2
  • Target Price
  • LEGN $79.00
  • TAL $15.30
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • TAL 8.5M
  • Earning Date
  • LEGN 05-12-2025
  • TAL 04-24-2025
  • Dividend Yield
  • LEGN N/A
  • TAL N/A
  • EPS Growth
  • LEGN N/A
  • TAL N/A
  • EPS
  • LEGN N/A
  • TAL 0.19
  • Revenue
  • LEGN $627,241,000.00
  • TAL $2,069,557,000.00
  • Revenue This Year
  • LEGN $66.92
  • TAL $53.31
  • Revenue Next Year
  • LEGN $51.77
  • TAL $33.96
  • P/E Ratio
  • LEGN N/A
  • TAL $50.51
  • Revenue Growth
  • LEGN 119.97
  • TAL 55.62
  • 52 Week Low
  • LEGN $29.27
  • TAL $7.35
  • 52 Week High
  • LEGN $60.87
  • TAL $15.30
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.92
  • TAL 31.90
  • Support Level
  • LEGN $29.27
  • TAL $9.50
  • Resistance Level
  • LEGN $35.11
  • TAL $10.35
  • Average True Range (ATR)
  • LEGN 1.89
  • TAL 0.69
  • MACD
  • LEGN 0.16
  • TAL -0.25
  • Stochastic Oscillator
  • LEGN 60.48
  • TAL 11.06

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About TAL TAL Education Group

TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions, and the like. Among those business lines, TAL focuses on enrichment learning and content solutions.

Share on Social Networks: